Colleen Newman

Colleen joined Centrexion in May 2021 as Vice President, Head of Clinical Operations. An experienced Pharmaceutical and Biotech Executive Leader with 30-years in Clinical Research, Colleen has held positions of increasing responsibility from Early Development to Post-Marketing in Clinical Operations, Clinical Science, and Clinical Quality, including extensive global NDA/BLA submission experience resulting in the successful approvals of 11 drugs and 1 cardiac device. Prior to joining Centrexion, Colleen was the Vice President, Head Clinical Operations and Clinical Quality at Editas Medicine. Colleen has also held Clinical Research, Operations, and Quality roles at Celgene Corporation, Merck, Schering-Plough Research Institute, Novartis, Pfizer, and Johnson and Johnson, incorporating a wide range of therapeutic experience including Oncology, Pain, Inflammation and Immunology, Women’s Health, Infectious Disease, Rare Disease, Gene Therapy, and Cardiac Devices. Colleen is a Registered Nurse and received her Bachelor of Science in Nursing from Northeastern University.